Best Esophageal cancer oncologists: TOP 144 doctors

• Dr. Bülent Karagöz specializes in esophageal cancer treatment with over 20 years of experience.
• Standard treatments include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.
• Dr. Karagöz has experience practicing at medical institutions of the NATO KFOR Command and Turkish Cypriot Peace Forces Command.
• Member of the Turkish Medical Oncology Association.
• Has written over 40 publications in cancer research.

• Specializes in the treatment of esophageal cancer, including surgery, chemotherapy, radiation therapy, and immunotherapy.
• Has practiced at medical institutions in the United States (University of Maryland Medical Center, Johns Hopkins Hospital) and Turkey.
• Certified by the European Society of Medical Oncology (ESMO) and a member of the European School of Oncology (ESO).
• Over 20 years of experience in oncology with numerous international and national publications.
• Languages spoken: English, Russian (B1 level), Turkish.

Dr. is a highly experienced surgeon with a specialization from Istanbul University and experience from various hospitals in Turkey. He is a member of multiple surgical societies and has completed various courses and certifications in the field of surgery.

• Mustafa Solak, M.D., specializes in the treatment of esophageal cancer with advanced expertise.
• Standard treatment methods for esophageal cancer include surgery, chemotherapy, radiation therapy, endoscopic procedures, and targeted therapy.
• International practice includes training at The University of Texas MD Anderson Cancer Center in the USA.
• Graduated from Hacettepe University School of Medicine and completed a fellowship at Hacettepe University Cancer Institute.
• Professional memberships: Turkish Medical Association, European Society for Medical Oncology (ESMO).

Assoc. Prof. Kıvanç Derya Peker has extensive experience in the medical field, specializing in Pancreatic Surgery, Gallbladder and Tracts Surgery, Liver Diseases Surgery, Stomach Diseases and Stomach Cancer Surgery, Obesity – Metabolic Surgery and Endoscopic Treatments, and Kidney Transplant. He has also done research into aging and treatments.

• Dr. Jaume Capdevila specializes in esophageal cancer treatment, offering chemotherapy, radiation therapy, surgery, and targeted therapy.
• He trained at Uppsala University Hospital in Sweden, focusing on Endocrine Oncology.
• He holds a degree in Medicine and Surgery from the University of Lleida and a specialization in Medical Oncology.
• Dr. Capdevila is a member of EORTC, ESMO, ENETS, ASCO, GEMCAD, TTD, and GETHI.
• He speaks multiple languages, which facilitates communication with patients from diverse backgrounds.

Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.

After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.

He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.

He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.

MEDICAL INTERESTS

MR-Linac

Linac

Stereotactic (Pinpoint) Radiotherapy

Prostate Cancers

Breast Cancers

Lung Cancers

Rectum Cancers

Brain and Spinal Cord Cancers

Head and Neck Cancers

Volumetric Arc Therapy (VMAT)

Intensity Modulated Radiotherapy (IMRT)

Specializations

Cancer Surgery

Pancreatic Surgery

Bile Duct Surgery

Bariatric Metabolic Surgery

Oncological Surgery

Breast Surgery

Gastric cancer

Colon cancer

Thyroid Cancer

Obesity Surgery

Diabetes Surgeries

Prof. Sadi Kerem Okutur is a Turkish medical oncologist with over 20 years of experience. He is currently working at Memorial Bahçelievler Hospital, and has held various positions in the past. He has a degree in general medicine, and a residency in internal medicine and medical oncology. Prof. Okutur has won a research award and authored numerous papers and book chapters. He is a member of various medical societies.

• Dr. Carlos Ballesta López specializes in esophageal cancer treatment with over 30 years of experience.
• He is an expert in laparoscopic surgery, which reduces pain and recovery time for patients with esophageal cancer.
• Standard treatment options include endoscopic resection, esophagectomy, chemotherapy, radiation therapy, and targeted therapy.
• Dr. López has international experience, having practiced at clinics in Spain and Latin America.
• He is certified by IFSO as a Center of Excellence in Bariatric and Metabolic Surgery.

• Prof. Fermín Mearin Manrique specializes in esophageal cancer treatment, utilizing surgery, chemotherapy, and radiation therapy.
• He has received extensive training at medical institutions in Spain, the Netherlands, and the USA, including the Mayo Clinic.
• With over 40 years of practice, he leads the Digestive Sy Service at Teknon Medical Center.
• He is a member of the American Gastroenterological Association and the Spanish Society of Digestive Pathology.
• He has authored over 400 scientific works, making significant contributions to gastroenterology research.

General and digestive tract surgeon with expertise in minimally invasive laparoscopic surgery. Has held Associate Clinical Lecturer and Lecturer positions at the University of Navarre School of Medicine. Member of the Spanish Association of Surgeons, Spanish Society of Obesity Surgery, and European Association for Endoscopic Surgery.

Professor Riccardo Rosati is the Head of the Gastrointestinal Surgery (GI) Department at the San Raffaele Research Hospital in Milan, Italy. He is a highly experienced surgeon with over 30 years of experience, having completed medical degrees in general medicine and general surgery, as well as specialization in thoracic surgery. He is a member of multiple surgical associations, and has written over 300 publications. His department treats approximately 2,000 surgical cases per year.

Dr. Ofer Merimsly is the best sarcoma, lymphoma, and lung cancer doctor within Israel and in the world. Also specializes in Whipple surgery treatment for patients with pancreatic cancer. Head of the National Center for sarcomas of bone and soft tissues of the Tel Aviv Medical Center Sourasky (Ichilov).

Specialty:

• Treatment of all types of lung cancer and thoracic organs
• Treatment of all types of sarcomas of bone and soft tissue
• Treatment stromal tumors of the gastrointestinal tract

Education and specialization:

• Higher medical education, graduated the Medical Faculty of the Hebrew University of Jerusalem, Israel
• Residency in General Oncology and Radiotherapy
• Training in the field of radiotherapy and brachytherapy at New York Hospital, USA
• Special refresher course for the treatment of tumors of the skeleton and soft tissues, Paris. France

Membership:

• President of the Society of oncologists and radiotherapists Israel
• The American Scientific Cancer Society
• European scientific medical organization
• European Society of Oncology of the musculoskeletal sy
• International Society for the treatment of tumors of the connective tissue

• Prof. Boris Pfaffenbach specializes in esophageal cancer treatment, utilizing endoscopic examinations and advanced surgical techniques.
• Standard treatment options for esophageal cancer include endoscopic resection, chemotherapy, radiation therapy, and minimally invasive esophagectomy.
• Prof. Pfaffenbach has experience of international practice at medical institutions in Germany, including Ruhr University of Bochum and Essen University Hospital.
• He is a member of the German Society of Gastroenterology, European Society of Gastroenterology and Endoscopy, and German Dietitian Association.
• He is the author and co-author of over 130 publications in gastroenterology and oncology.

Prof. Nadir Arber is a top gastroenterologist from Israel with over 30 years of experience in the field. He is specialized in the prevention, early diagnostics, and treatment of GI cancers, with education from Hebrew University, Tel Aviv University, and NewYork-Presbyterian Center. He has written over 300 papers on his research and is a member of numerous organizations in the field.

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations